[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370451-105":59,"doc-detail-370451-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","integrins-in-cancer-drug-resistance-molecular-mechanisms-and-clinical-implications","Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications","","Cancer mortality is largely driven by intrinsic and acquired drug resistance, and overcoming this resistance is a central challenge in treatment. Integrins are transmembrane adhesion molecules that connect the extracellular matrix (ECM) to the cytoskeleton and activate signaling pathways linked to cancer progression, invasion, and metastasis. This review summarizes integrin function and classification, then highlights recent findings on how integrins contribute to drug resistance through ECM interactions, drug transporters, EMT, cancer stemness, PD-L1 regulation, and glycosylation. It concludes with therapeutic implications for targeting integrins in drug-resistant cancers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrins-in-cancer-drug-resistance-molecular-mechanisms-and-clinical-implications/370451/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrins-in-cancer-drug-resistance-molecular-mechanisms-and-clinical-implications/370451.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-16","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Why is drug resistance considered a major obstacle in cancer treatment?","Question",{"text":113,"@type":114},"A high proportion of cancer mortality is directly or indirectly related to drug resistance during treatment, making it a key challenge to address.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do integrins contribute to drug resistance in cancer?",{"text":118,"@type":114},"Integrins regulate cell survival and signaling by linking the ECM to the cytoskeleton, which can promote progression and therapy resistance, including CAM-DR mechanisms.",{"name":120,"@type":111,"acceptedAnswer":121},"Which topics does the review cover regarding integrin-mediated drug resistance?",{"text":122,"@type":114},"It discusses recent advances focusing on ECM interactions, drug transporters, EMT, cancer stemness, PD-L1, and glycosylation, and summarizes potential therapeutic targeting of integrins.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370451,1790408114,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nIntegrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications  \nYoshinobu Kariya * and Michiru Nishita  \nDepartment of Biochemistry, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Fukushima, Japan  \n* Correspondence: [kariya@fmu.ac.jp](kariya@fmu.ac.jp); Tel.: +81-24-547-1144  \nAbstract: It is estimated that between 80 and 90% of mortality in cancer patients is directly or indirectly related to drug resistance. Consequently, overcoming drug resistance represents a significant challenge in the treatment of cancer. Integrins are transmembrane adhesion molecules that facilitate the linkage between the extracellular matrix (ECM) and the cytoskeleton, thereby enabling the activation of various cellular signaling pathways. Integrins are highly expressed in various cancers and contribute to cancer progression through invasion and metastasis. In addition, recent studies have revealed that integrins play a pivotal role in the development of drug resistance in cancer. This review will first provide an overview of integrin function and classification. It then discusses recent advancesin understanding how integrins contribute to drug resistance in cancer, with a focus on ECM, drug transporters, the epithelial-to-mesenchymal transition (EMT), cancer stemness, PD-L1, and glycosylation. Finally, the potential applications of integrins as targets for therapeutic agents against drug-resistant cancers are also summarized.  \nKeywords: drug resistance; cancer; integrin; drug transporter; extracellular matrix (ECM); epithelial-to-mesenchymal transition (EMT); cancer stem cell (CSC); tyrosine kinase inhibitor (TKI); PD-L1; glycosylation  \nAcademic Editor: Kazuyuki Matsushita  \nReceived: 3 March 2025  \nRevised: 26 March 2025  \nAccepted: 26 March 2025  \nPublished: 28 March 2025  \nCitation: Kariya, Y.; Nishita, M. Integrins in Cancer Drug Resistance:  \nMolecular Mechanisms and Clinical Implications. Int. J. Mol. Sci. 2025, 26, 3143. [https://doi.org/10.3390/](https://doi.org/10.3390/)[ ](https://doi.org/10.3390/)ijms26073143  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1. Introduction  \nIn 2022, the Albert Lasker Basic Medical Award was presented to three scientists, Richard Hynes, Erkki Ruoslathi, and Timothy Springer, in recognition of their contributions to the field of integrin research. This was a milestone in the history of integrin research. Today, 40 years have passed since integrins were first discovered [1] . During that time, many researchers have intensively studied the physiological and pathological roles of integrins. It is now well established that integrins play a pivotal role in regulating cellular functions and are also involved in the pathogenesis of various diseases, including cancers, cardiovascular diseases, inflammatory diseases, fibrosis, autoimmune diseases, and Alzheimer’s disease [2] . This has prompted numerous researchers and pharmaceutical companies to develop drugs that target integrins [3] . To date, drugs targeting the Arg-GlyAsp (RGD)-binding αIIbβ3 integrin have been developed for the treatment of thrombotic cardiovascular events, αLβ2 for dry eye, and α4β7 and α4β1 integrins for ulcerative colitis, Crohn’s disease, and multiple sclerosis [3,4] . On the other hand, despite great efforts, the development of integrin-targeted therapeutics for cancer has not been successful [4,5] .  \nA significant proportion of tumors demonstrate intrinsic or acquired resistance to anticancer drugs during the course of treatment, and approximately 80–90% of mortality in cancer patients is directly or indirectly related to drug resistance [6] . Therefore, drug  \nresistance is a challenge that m","cbCaigoIKS1Osqzs","https://ap.wps.com/l/cbCaigoIKS1Osqzs","pdf",2512106,27,"English","# Introduction\n## Integrins and their role in cancer research\n## Cell adhesion-mediated drug resistance (CAM-DR) in tumors\n# Table 1: CAM-DR in solid tumors","[{\"question\":\"Why is drug resistance considered a major obstacle in cancer treatment?\",\"answer\":\"A high proportion of cancer mortality is directly or indirectly related to drug resistance during treatment, making it a key challenge to address.\"},{\"question\":\"How do integrins contribute to drug resistance in cancer?\",\"answer\":\"Integrins regulate cell survival and signaling by linking the ECM to the cytoskeleton, which can promote progression and therapy resistance, including CAM-DR mechanisms.\"},{\"question\":\"Which topics does the review cover regarding integrin-mediated drug resistance?\",\"answer\":\"It discusses recent advances focusing on ECM interactions, drug transporters, EMT, cancer stemness, PD-L1, and glycosylation, and summarizes potential therapeutic targeting of integrins.\"}]","Integrins in Cancer Drug Resistance: Molecular Mechanisms and Clinical Implications | PDF",1790188546,68,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/940f98c42f601c04c619ef560130b517.webp",983,1390,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7dc4b48ea54dfa6dfafd0b95d989193.webp",982,1388,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4a6b733bc1d3dc7a454b60de554df4e0.webp",981,1387,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e00faf4be145cc55b69bd389547abf9b.webp",980,1385]